Literature DB >> 22232435

Mesenchymal stem cells induce functionally active T-regulatory lymphocytes in a paracrine fashion and ameliorate experimental autoimmune uveitis.

Roberta Tasso1, Cristina Ilengo, Rodolfo Quarto, Ranieri Cancedda, Rachel R Caspi, Giuseppina Pennesi.   

Abstract

PURPOSE: Mesenchymal stem/progenitor cells (MSCs) have regenerative and immunomodulatory properties, exerted by cell-cell contact and in a paracrine fashion. Part of their immunosuppressive activity has been ascribed to their ability to promote the induction of CD4+CD25+FoxP3+ T lymphocytes with regulatory functions (Treg). Here the authors studied the effect of MSCs on the induction of Treg and on the development of autoimmunity, and they examined the possibility that MSC-mediated Treg induction could be attributed to the secretion of soluble factors.
METHODS: The authors induced experimental autoimmune uveitis (EAU) in mice by immunization with the 1-20 peptide of the intraphotoreceptor binding protein. At the same time, some of the animals were treated intraperitoneally with syngeneic MSCs. The authors checked T-cell responses and in vitro Treg conversion by cell proliferation and blocking assays, in cell-cell contact and transwell settings. TGFβ and TGFβ receptor gene expression analyses were performed by real-time PCR.
RESULTS: The authors found that a single intraperitoneal injection of MSCs was able to significantly attenuate EAU and that a significantly higher percentage of adaptive Treg was present in MSC-treated mice than in MSC-untreated animals. In vitro blocking of antigen presentation by major histocompatibility complex class II precluded priming and clonal expansion of antigen-specific Treg, whereas blockade of TGFβ impaired the expression of FoxP3, preventing the conversion of CD4+ T cells into functionally active Treg.
CONCLUSIONS: The authors demonstrated that MSCs can inhibit EAU and that their immunomodulatory function is due at least in part to the induction of antigen-specific Treg in a paracrine fashion by secreting TGFβ.

Entities:  

Mesh:

Year:  2012        PMID: 22232435      PMCID: PMC3317420          DOI: 10.1167/iovs.11-8211

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  43 in total

1.  Residues 1-20 of IRBP and whole IRBP elicit different uveitogenic and immunological responses in interferon gamma deficient mice.

Authors:  D Avichezer; C C Chan; P B Silver; B Wiggert; R R Caspi
Journal:  Exp Eye Res       Date:  2000-08       Impact factor: 3.467

2.  Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells.

Authors:  Katarina Le Blanc; Ida Rasmusson; Berit Sundberg; Cecilia Götherström; Moustapha Hassan; Mehmet Uzunel; Olle Ringdén
Journal:  Lancet       Date:  2004-05-01       Impact factor: 79.321

3.  Identification of a peptide inducing experimental autoimmune uveoretinitis (EAU) in H-2Ak-carrying mice.

Authors:  K Namba; K Ogasawara; N Kitaichi; N Matsuki; A Takahashi; Y Sasamoto; S Kotake; H Matsuda; K Iwabuchi; S Ohno; K Onoé
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

4.  A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens.

Authors:  R R Caspi; F G Roberge; C C Chan; B Wiggert; G J Chader; L A Rozenszajn; Z Lando; R B Nussenblatt
Journal:  J Immunol       Date:  1988-03-01       Impact factor: 5.422

5.  Genetic control of susceptibility to experimental autoimmune uveoretinitis in the mouse model. Concomitant regulation by MHC and non-MHC genes.

Authors:  R R Caspi; B G Grubbs; C C Chan; G J Chader; B Wiggert
Journal:  J Immunol       Date:  1992-04-15       Impact factor: 5.422

6.  Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential.

Authors:  Alexandra Peister; Jason A Mellad; Benjamin L Larson; Brett M Hall; Laura F Gibson; Darwin J Prockop
Journal:  Blood       Date:  2003-10-30       Impact factor: 22.113

7.  Identification of a major pathogenic epitope in the human IRBP molecule recognized by mice of the H-2r haplotype.

Authors:  P B Silver; L V Rizzo; C C Chan; L A Donoso; B Wiggert; R R Caspi
Journal:  Invest Ophthalmol Vis Sci       Date:  1995-04       Impact factor: 4.799

8.  A humanized model of experimental autoimmune uveitis in HLA class II transgenic mice.

Authors:  Giuseppina Pennesi; Mary J Mattapallil; Shu-Hui Sun; Dody Avichezer; Phyllis B Silver; Zaruhi Karabekian; Chella S David; Paul A Hargrave; J Hugh McDowell; W Clay Smith; Barbara Wiggert; Larry A Donoso; Chi-Chao Chan; Rachel R Caspi
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

9.  Isolation and characterisation of mesenchymal stem cells from adult mouse bone marrow.

Authors:  Philippe Tropel; Danièle Noël; Nadine Platet; Pierre Legrand; Alim-Louis Benabid; François Berger
Journal:  Exp Cell Res       Date:  2004-05-01       Impact factor: 3.905

10.  Retinal S-antigen: immunocytochemical and immunochemical studies on distribution in animal photoreceptors and pineal organs.

Authors:  T van Veen; R Elofsson; H G Hartwig; I Gery; M Mochizuki; V Ceña; D C Klein
Journal:  Exp Biol       Date:  1986
View more
  41 in total

Review 1.  Factors governing the immunosuppressive effects of multipotent mesenchymal stromal cells in vitro.

Authors:  Aleksandra Gornostaeva; Elena Andreeva; Ludmila Buravkova
Journal:  Cytotechnology       Date:  2015-08-13       Impact factor: 2.058

2.  Mesenchymal stem cell population derived from human pluripotent stem cells displays potent immunomodulatory and therapeutic properties.

Authors:  Erin A Kimbrel; Nicholas A Kouris; Gregory J Yavanian; Jianlin Chu; Yu Qin; Ann Chan; Ram P Singh; Deborah McCurdy; Lynn Gordon; Ralph D Levinson; Robert Lanza
Journal:  Stem Cells Dev       Date:  2014-05-02       Impact factor: 3.272

3.  Therapeutic effects of stress-programmed lymphocytes transferred to chronically stressed mice.

Authors:  Rachel B Scheinert; Mitra H Haeri; Michael L Lehmann; Miles Herkenham
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2016-04-21       Impact factor: 5.067

Review 4.  Interactions between mesenchymal stem cells and the immune system.

Authors:  Na Li; Jinlian Hua
Journal:  Cell Mol Life Sci       Date:  2017-02-18       Impact factor: 9.261

5.  The effect of mesenchymal stem cells on dynamic changes of T cell subsets in experimental autoimmune uveoretinitis.

Authors:  G Li; L Yuan; X Ren; H Nian; L Zhang; Z C Han; X Li; X Zhang
Journal:  Clin Exp Immunol       Date:  2013-07       Impact factor: 4.330

6.  Long-term therapeutic effects of mesenchymal stem cells compared to dexamethasone on recurrent experimental autoimmune uveitis of rats.

Authors:  Lingjun Zhang; Hui Zheng; Hui Shao; Hong Nian; Yan Zhang; Lingling Bai; Chang Su; Xun Liu; Lijie Dong; Xiaorong Li; Xiaomin Zhang
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-14       Impact factor: 4.799

7.  Platelet-Derived Growth Factor-BB Protects Mesenchymal Stem Cells (MSCs) Derived From Immune Thrombocytopenia Patients Against Apoptosis and Senescence and Maintains MSC-Mediated Immunosuppression.

Authors:  Jia-Min Zhang; Fei-Er Feng; Qian-Ming Wang; Xiao-Lu Zhu; Hai-Xia Fu; Lan-Ping Xu; Kai-Yan Liu; Xiao-Jun Huang; Xiao-Hui Zhang
Journal:  Stem Cells Transl Med       Date:  2016-07-28       Impact factor: 6.940

8.  Tregs in Autoimmune Uveitis.

Authors:  Zhaohao Huang; Wenli Li; Wenru Su
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  Mesenchymal stromal cells mediate Aspergillus hyphal extract-induced allergic airway inflammation by inhibition of the Th17 signaling pathway.

Authors:  Melissa J Lathrop; Elice M Brooks; Nick R Bonenfant; Dino Sokocevic; Zachary D Borg; Meagan Goodwin; Roberto Loi; Fernanda Cruz; Chad W Dunaway; Chad Steele; Daniel J Weiss
Journal:  Stem Cells Transl Med       Date:  2014-01-16       Impact factor: 6.940

Review 10.  Mesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal models.

Authors:  Matthew W Klinker; Cheng-Hong Wei
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.